Search - tctmd.com

Displaying 581 - 600 of 1776

Sort: Relevancy | Date

Presentation TCT 2017

My Technique for: Atherectomy Via Radial Access

Presenter: Olivier F. Bertrand, Yves R. Louvard, Prashant Kaul

October 30, 2017

Presentation TCT 2017

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter

October 30, 2017

Presentation TCT 2017

Radial First (Nearly) Always

Presenter: Jennifer A. Tremmel

October 30, 2017

Presentation TCT 2017

Hong Kong Presents: How I Treated This Complex CTO

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Li-Wah Tam

October 30, 2017

Presentation TCT 2017

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

Italy Presents a Case: Ostial Dissection in a STEMI Patient

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Corrado Lettieri

October 30, 2017

Presentation TCT 2017

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Presenter: Fernando Alfonso, Patrick W. Serruys, William F. Fearon

October 30, 2017

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Gennaro Giustino

October 30, 2017

Presentation TCT 2017

Hungary Presents: How Should I Treat This Complex CTO?

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

My Technique for: High-Risk Transradial Unprotected Left Main PCI

Presenter: Olivier F. Bertrand, Yves R. Louvard, Mauricio G. Cohen

October 30, 2017

Presentation TCT 2017

Hong Kong Presents: My Worst Complication During a CTO PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Li-Wah Tam

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Issam D. Moussa, Manesh R. Patel

October 30, 2017

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? Yes, Based on TROPICAL-ACS, TRITON, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Dirk Sibbing

October 30, 2017

Presentation TCT 2017

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani

October 30, 2017

Presentation TCT 2017

Hungary Presents: Complications During CTO PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Istvan F. Edes

October 30, 2017

Presentation TCT 2017

Israel Presents a Case: STEMI With Cardiogenic Shock

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Amit Segev

October 30, 2017

Presentation TCT 2017

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham

October 30, 2017

Presentation TCT 2017

My Technique for: Transradial CTO PCI

Presenter: Olivier F. Bertrand, Yves R. Louvard, Stéphane Rinfret

October 30, 2017

Advertisement

My Technique for: Atherectomy Via Radial Access

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Radial First (Nearly) Always

Hong Kong Presents: How I Treated This Complex CTO

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Italy Presents a Case: Ostial Dissection in a STEMI Patient

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Hungary Presents: How Should I Treat This Complex CTO?

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

My Technique for: High-Risk Transradial Unprotected Left Main PCI

Hong Kong Presents: My Worst Complication During a CTO PCI

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? Yes, Based on TROPICAL-ACS, TRITON, and Other Studies!

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Hungary Presents: Complications During CTO PCI

Israel Presents a Case: STEMI With Cardiogenic Shock

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

My Technique for: Transradial CTO PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content